Live Breaking News & Updates on Debral Richardson|Page 1

Stay updated with breaking news from Debral richardson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Richardson on the Safety of Upifitamab Rilsodotin in Platinum-Resistant Ovarian Cancer

Debra L. Richardson, MD, FACS, FACOG, discusses the safety profile of upifitamab rilsodotin in the phase 1/2 UPLIFT trial of patients with ovarian cancer.
....

United States , University Of Oklahoma , Debral Richardson , Phasei Program , Ou Health , University Of Oklahoma Ou College Medicine , Stephenson Cancer Center , Gynecologic Oncology , Stephenson Cancer Center , Ovarian Cancer , Onclive Tv ,

Dr Richardson on the UPLIFT Trial of Upifitamab Rilsodotin in Ovarian Cancer

Debra L. Richardson, MD, FACS, FACOG, discusses outcomes seen with upifitamab rilsodotin in the phase 1/2 UPLIFT trial for patients with ovarian cancer. ....

United States , University Of Oklahoma , Debral Richardson , Phasei Program , University Of Oklahoma Ou College Medicine , Stephenson Cancer Center , Ou Health , Gynecologic Oncology ,

Journey Ends for Upifitamab Rilsodotin in NaPi2b+ Platinum-Resistant Ovarian Cancer

Debra L. Richardson, MD, FACS, FACOG, expands on results with upifitamab rilsodotin in platinum-resistant high-grade serous ovarian cancer. ....

University Of Oklahoma , United States , Oklahoma City , Debral Richardson , Phasei Program , Ou Health , Stephenson Cancer Center , University Of Oklahoma Ou College Medicine , Gynecologic Oncology , Upifitamab Rilsodotin , Platinum Resistant High Grade Serous Ovarian Cancer , The University Of Oklahoma College Medicine ,

Dr Richardson on the Efficacy of Selinexor in TP53 Wild-Type Endometrial Cancer

Debra L. Richardson, MD, FACS, FACOG, discusses the impact of selinexor’s mechanism of action on the agent’s clinical efficacy in patients with TP53 wild-type advanced or recurrent endometrial cancer. ....

United States , University Of Oklahoma , Debral Richardson , University Of Oklahoma Ou College Medicine , Stephenson Cancer Center , Phasei Program , Ou Health , Gynecologic Oncology , Global Meeting , Endometrial Cancer ,